Chemoinformaics analysis of Pterosin B benzoate
| Molecular Weight | 322.404 | nRot | 4 |
| Heavy Atom Molecular Weight | 300.228 | nRig | 18 |
| Exact Molecular Weight | 322.157 | nRing | 3 |
| Solubility: LogS | -6.271 | nHRing | 0 |
| Solubility: LogP | 4.796 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 52.1454 |
| nHD | 0 | BPOL | 25.5426 |
| QED | 0.797 |
| Synth | 2.826 |
| Natural Product Likeliness | 0.971 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.983 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.896 |
| MDCK | 0.0000264 |
| BBB | 0.03 |
| PPB | 0.997217 |
| VDSS | 1.15 |
| FU | 0.0080394 |
| CYP1A2-inh | 0.834 |
| CYP1A2-sub | 0.824 |
| CYP2c19-inh | 0.934 |
| CYP2c19-sub | 0.212 |
| CYP2c9-inh | 0.836 |
| CYP2c9-sub | 0.866 |
| CYP2d6-inh | 0.644 |
| CYP2d6-sub | 0.855 |
| CYP3a4-inh | 0.805 |
| CYP3a4-sub | 0.392 |
| CL | 9.825 |
| T12 | 0.137 |
| hERG | 0.038 |
| Ames | 0.128 |
| ROA | 0.097 |
| SkinSen | 0.508 |
| Carcinogencity | 0.584 |
| EI | 0.536 |
| Respiratory | 0.165 |
| NR-Aromatase | 0.565 |
| Antiviral | No |
| Prediction | 0.607361 |